Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
33,058
Sort by:
Booming Clinical Trials Market in India
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 India has billion plus population and a home for various life threate...
August 2011
145 pages
Booming Generics Drug Market in India
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 The world has witnessed a sharp increase in the demand for cost-effec...
August 2011
60 pages
Pharma Marketing Excellence: Lessons from Experience
US$ 595.00
Marketing excellence. Over the past five years, those two words have been the subject of hype and the focus of management attention. As the pharmaceutical industry struggles with market maturation and...
August 2011
45 pages
Digital Marketing Talent: Who Is Pharma hiring?
US$ 495.00
Digital technology—it's everywhere you look. And nowhere is the impact of digital technology more apparent than new digital job creations and hiring practices within the pharmaceutical industry.
...
August 2011
37 pages
Pharmacovigilance and Related Developments 2011-2021
US$ 2,325.00
... and three research interviews (see the accompanying lists). Pharmacovigilance and Related Developments 2011-2021 shows you opportunities, challenges and forecasts ... report is for everybody needing industry and market analysis for pharmacovigilance. Find trends and answers. Avoid missing out - please order ...
August 2011
117 pages
Market Access Brazil: Unlocking Pharma Potential
US$ 795.00
With this year’s election of president Dilma Rousseff, Brazil has indicated a willingness to encourage long-term foreign investment in the pharmaceutical industry. Yet while Rousseff has set three cri...
July 2011
38 pages
The Impact of iPads on pharma: a Primer
US$ 245.00
With the launch of Apple's iPad in April 2010, the way we use technology changed forever. Instant, portable and quick, the iPad is expected to sell 50 million units in 2011 alone.
Its impact...
July 2011
33 pages
U.S. Hyaluronic Acid Viscosupplementation Physician Survey 2011
US$ 7,495.00
Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid ...
July 2011
80 pages
International Hyaluronic Acid Viscosupplementation Physician Survey 2011
US$ 11,495.00
Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid ...
July 2011
91 pages
Generic Drugs in Consumer Health Global Overview 2011
US$ 2,000.00
... are slowly becoming an ally in a strategy to boost sales. Euromonitor International’s Generic Drugs in Consumer Health Global Overview 2011 global briefing examines the ... data. Why buy this report? Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving ...
July 2011
50 pages
Para IV Pipeline Analysis of Indian Pharma Companies
US$ 400.00
... cliff of 2014, many of the Indian companies are choosing the Para IV route to grab a higher market share, both in value and volume ... world’s top 11 products under litigation. This report is a comprehensive study of Para IV pipeline of the Indian companies and likely upside from each of the ...
June 2011
214 pages
Global Obesity Drug Market Analysis
US$ 1,000.00
Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The obesity epidemic has been disseminating among developed countries as well as low...
June 2011
85 pages
Pharma on Twitter: Developing a Presence
US$ 395.00
Does your company have a Twitter account? Want to know what all the buzz is about? Whether you are an experienced Twitter user or just curious, Pharma on Twitter: Developing a Presence, shares first-h...
June 2011
56 pages
Analyzing the Major Pharmaceutical Markets
US$ 300.00
... the knowledge employment ratios globally. Aruvian's R'search’s report – Analyzing the Major Pharmaceutical Markets - globally is a complete ready country reckoner which offers the analyst ...
June 2011
100 pages
Looking at Offshoring in the Pharmaceutical Industry
US$ 300.00
... expand their global pharmaceutical revenues. Aruvian's R'search’s report – Looking at Offshoring in the Pharmaceutical Industry - is a detailed analysis of the ... employment scenarios in emerging and growing economies. The impact of Offshoring as a practice cannot be understood without a complete study of ...
June 2011
50 pages
Competitor Analysis: Hepatitis Vaccines
US$ 498.00
... Vaccines Combination Vaccines including HAV Vaccines Combination Vaccines including HBV Vaccines Hepatitis C Virus Vaccines Hepatitis E Virus Vaccines Corporate Hepatitis Vaccine Product Portfolios and R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but ...
June 2011
96 pages
Emerging Pharmaceutical Markets 2012
US$ 3,907.00
... to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research ... therapeutic segments, different and complex regulatory law and a fragmented market. The worldwide economic crisis has also added a new layer ...
May 2011
222 pages
Clinical Trials Market in Russia
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 The clinical trials market in Russia is one of the vibrant sectors in...
May 2011
50 pages
Drug Combinations: New Rules, New Opportunities
US$ 895.00
Single symptom. Single illness. Single drug.
For years, drug therapy has been built on that basic equation. Yet as genomic biology sheds light on the astonishing intricacy of disease patholo...
May 2011
48 pages
Keys for Pharma Success: Integrating Social
US$ 595.00
Pharma companies began their journey in social media over four years ago with a single initiative, often a Twitter account. Subsequently, they have embarked upon a process of layering their digital fo...
May 2011
51 pages
Vitamins and Dietary Supplements in Indonesia
US$ 900.00
Vitamins and dietary supplements continued to record healthy double-digit current retail value growth in 2010, with sales being boosted by the increasing popularity of preventive medicine, especially...
May 2011
44 pages
Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021
US$ 2,325.00
... and a research interview (shown in the accompanying lists). Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 shows you revenue ... technologies in development, assessing potential among the R&D product candidates for ACS You will investigate competition and opportunities influencing the industry ...
May 2011
132 pages
Competitor Analysis Influenza Vaccines
US$ 718.00
... of seasonal and pandemic influenza disease. In addition, the report lists company-specific product portfolios and R&D pipelines of influenza vaccines on the market and in R&D. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of ...
May 2011
123 pages
Middle East and Africa Pharma Sector Forecast to 2012
US$ 1,200.00
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,400.00
CD-ROM: US$ 1,400.00 of market defining regulations and increasing expenditure on healthca...
April 2011
80 pages
Global Alzheimer Prevalence and Drugs Demand
US$ 630.00
EXECUTIVE SUMMARY
The report on “Global Alzheimer Prevalence and Drugs Demand” includes the overall market for the treatment of Alzheimer, performance of drugs by sales and market share. In...
April 2011
37 pages
Production, Market and Benchmarking of Synthetic Vitamin E in China
US$ 14,897.00
... vitamin E producers’ competitiveness in China, CCM did production benchmarking analysis of three major vitamin E producers in China. What is the detailed ... in China in 2011? This report combines CCM’s expertise in vitamin E market research. Aspects as follows can be expected: Production situation ...
April 2011
57 pages
Bangladesh Vitamins & Minerals Market Report & Forecasts
US$ 750.00
IMARC’s new report “Bangladesh Vitamins & Minerals Market Report & Forecasts” provides an analytical and statistical insight into the Bangladesh vitamins and minerals market. The report provides both...
April 2011
147 pages
Competitor Analysis: Emerging Diabetes Drugs
US$ 870.00
Product description The present Competitive Intelligence Report about Emerging Diabetes Drugs provides a competitor evaluation in the field of novel molecules against a series of novel targets being developed for treatment of type 1 or 2 diabetes as of April 2011. Pharmacologic approaches include SGLT ...
April 2011
104 pages
Russian Pharma Sector Forecast to 2013
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,200.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 The Russian pharma industry is one of the most prolific sectors in the heal...
March 2011
100 pages
Asian Vaccine Markets
US$ 3,500.00
The Asian vaccines market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets....
March 2011
180 pages
Pharma Blogging: Speaking Out
US$ 495.00
Blogging offers Pharma companies the opportunity to engage with key constituencies in an informal manner, the ability to present their interpretation of stories pertaining to their organization in the...
March 2011
42 pages
World Diabetes Drug Market 2011-2021
US$ 2,325.00
... , Levemir, Actraphane HM, Actos, Avandia, Avandamet, Januvia and Byetta will perform to 2021. We also discuss insulin delivery technologies. Our review of research and ... for you to stay ahead in this industry and market. World Diabetes Drug Market 2011-2021 shows you revenue trends, opportunities and ...
March 2011
224 pages
Analgesics - Hong Kong, China
US$ 900.00
Analgesics continued to see steady growth in value sales in 2010, of 4%, which was in line with the review period average. Growth was driven by a strong performance by topical analgesics.
Eur...
March 2011
25 pages
Calming and Sleeping - Czech Republic
US$ 900.00
Calming and sleeping recorded a healthy review period current retail value CAGR of 3%. Consumption in this area is being fuelled by the fact that the increasingly hectic and stressful pace of modern l...
March 2011
24 pages
Calming and Sleeping - Hong Kong, China
US$ 900.00
The high stress levels experienced by many Hong Kong residents is believed to be the main factor causing insomnia. Some people purchase over-the-counter products for treatment; however, many simply se...
March 2011
23 pages
Digestive Remedies - Czech Republic
US$ 900.00
Digestive remedies recorded relatively stable growth over the review period, with constant retail value sales increasing at an average annual rate of 3%. The consumption of digestive remedies is being...
March 2011
26 pages
Digestive Remedies - Hong Kong, China
US$ 900.00
In March 2010, the Department of Health ordered that all products from Li Chung Shing Tong (Holdings) Ltd, including Po Chai Pills Capsule Form and Po Chai Pills Bottle Form, be recalled from local re...
March 2011
25 pages
NRT Smoking Cessation Aids - Czech Republic
US$ 900.00
NRT smoking cessation aids recorded good current retail value growth of 2% in 2010. Although products in this area are relatively expensive, quitting smoking is an excellent way of reducing household...
March 2011
26 pages
NRT Smoking Cessation Aids - Hong Kong, China
US$ 900.00
In 2010, the government launched a TV advertising campaign to promote a smoke-free culture. Since 2007, the government has been gradually increasing the number of places where smoking is prohibited. C...
March 2011
24 pages
